Drugs / Flouxetine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07417046 Comparator | Dec 2024 → Mar 2026 overdue | amblyopia | Minia University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flouxetine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07417046 ↗ |
| Action | Activate | “Selective serotonin reuptake inhibitors (SSRIs) increase serotonin activity in the brain.” NCT07417046 ↗ |